Come up with a name for your new list and we'll add to it:
Ancora Pharmaceuticals raised a round of funding on May 16, 2008. Investors include
Harris & Harris Group.
Ancora Pharmaceuticals aims to enable synthetic carbohydrate-based product discovery and development utilizing its carbohydrate synthesis capability, which is based on technology originally developed …